GET DAILY SIGNALSCI is expected to report earnings to rise+6.45% to $5.28 per share on May 05
CI (Cigna Corporation) is set to report its earnings on May 05, and the financial world is anticipating a 6.45% increase in earnings to $5.28 per share. This news has generated a lot of buzz among investors and analysts, who are closely monitoring the company's financial performance.
Cigna is a major player in the healthcare industry, providing a range of health insurance and related services to customers across the United States. The company's earnings report is a crucial indicator of its financial health and provides valuable insights into its growth prospects.
The expected 6.45% increase in earnings per share is a positive sign for Cigna and its investors, suggesting that the company's business is performing well and is on track for continued growth. However, it is important to note that earnings forecasts are just that - forecasts - and there is always some degree of uncertainty surrounding such predictions.
Investors and analysts will be closely scrutinizing Cigna's earnings report for any signs of weakness or areas of concern. They will be looking at factors such as revenue growth, profit margins, and cash flow to assess the company's financial health and growth potential.
In addition to its financial performance, Cigna is also facing a rapidly changing healthcare landscape, with new regulations, technological advancements, and shifting consumer preferences all impacting the industry. The company's ability to adapt and innovate in response to these challenges will be a key factor in its long-term success.
Overall, the anticipated increase in earnings per share is a positive development for Cigna and its investors, but it is important to approach such forecasts with a degree of caution and to closely monitor the company's performance and broader industry trends in the coming months and years.
Contributor
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
CI in upward trend: 10-day moving average moved above 50-day moving average on October 14, 2026
The 10-day moving average for CI crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on CI as a result. In 59 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CI just turned positive on October 07, 2026. Looking at past instances where CI's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.
CI moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for CI moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 222 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The 10-day RSI Indicator for CI moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 25 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 69 cases where CI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
CI broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.849) is normal, around the industry mean (3.447). P/E Ratio (12.270) is within average values for comparable stocks, (124.444). Projected Growth (PEG Ratio) (0.739) is also within normal values, averaging (0.786). CI has a moderately high Dividend Yield (0.021) as compared to the industry average of (0.009). P/S Ratio (0.264) is also within normal values, averaging (0.569).
The Tickeron Price Growth Rating for this company is 30 (best 1 - 100 worst), indicating outstanding price growth. CI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of health insurance services
Industry ManagedHealthCare
Advertisement